Annual Accounts Payable
$204.00 K
+$29.00 K+16.57%
December 31, 2023
Summary
- As of February 26, 2025, RGLS annual accounts payable is $204.00 thousand, with the most recent change of +$29.00 thousand (+16.57%) on December 31, 2023.
- During the last 3 years, RGLS annual accounts payable has fallen by -$331.00 thousand (-61.87%).
- RGLS annual accounts payable is now -96.51% below its all-time high of $5.84 million, reached on December 31, 2016.
Performance
RGLS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$792.00 K
+$191.00 K+31.78%
September 30, 2024
Summary
- As of February 26, 2025, RGLS quarterly accounts payable is $792.00 thousand, with the most recent change of +$191.00 thousand (+31.78%) on September 30, 2024.
- Over the past year, RGLS quarterly accounts payable has stayed the same.
- RGLS quarterly accounts payable is now -86.44% below its all-time high of $5.84 million, reached on December 31, 2016.
Performance
RGLS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RGLS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.6% | 0.0% |
| 3 y3 years | -61.9% | +33.1% |
| 5 y5 years | -88.1% | -47.9% |
RGLS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.4% | +16.6% | -0.5% | +352.6% |
| 5 y | 5-year | -84.6% | +16.6% | -43.1% | +352.6% |
| alltime | all time | -96.5% | +16.6% | -86.4% | +352.6% |
Regulus Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $792.00 K(+31.8%) |
| Jun 2024 | - | $601.00 K(+48.0%) |
| Mar 2024 | - | $406.00 K(+99.0%) |
| Dec 2023 | $204.00 K(+16.6%) | $204.00 K(-65.9%) |
| Sep 2023 | - | $599.00 K(+65.5%) |
| Jun 2023 | - | $362.00 K(-37.7%) |
| Mar 2023 | - | $581.00 K(+232.0%) |
| Dec 2022 | $175.00 K(-38.6%) | $175.00 K(-78.0%) |
| Sep 2022 | - | $796.00 K(+33.8%) |
| Jun 2022 | - | $595.00 K(-4.8%) |
| Mar 2022 | - | $625.00 K(+119.3%) |
| Dec 2021 | $285.00 K(-46.7%) | $285.00 K(-51.4%) |
| Sep 2021 | - | $586.00 K(-57.9%) |
| Jun 2021 | - | $1.39 M(+72.0%) |
| Mar 2021 | - | $810.00 K(+51.4%) |
| Dec 2020 | $535.00 K(-59.5%) | $535.00 K(-51.5%) |
| Sep 2020 | - | $1.10 M(+7.6%) |
| Jun 2020 | - | $1.02 M(-0.6%) |
| Mar 2020 | - | $1.03 M(-22.0%) |
| Dec 2019 | $1.32 M(-22.9%) | $1.32 M(-13.1%) |
| Sep 2019 | - | $1.52 M(-5.1%) |
| Jun 2019 | - | $1.60 M(-39.5%) |
| Mar 2019 | - | $2.65 M(+54.6%) |
| Dec 2018 | $1.71 M | $1.71 M(+38.8%) |
| Sep 2018 | - | $1.24 M(-77.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $5.47 M(+24.4%) |
| Mar 2018 | - | $4.40 M(-23.5%) |
| Dec 2017 | $5.74 M(-1.7%) | $5.74 M(+9.8%) |
| Sep 2017 | - | $5.23 M(+6.7%) |
| Jun 2017 | - | $4.90 M(+8.7%) |
| Mar 2017 | - | $4.51 M(-22.8%) |
| Dec 2016 | $5.84 M(+114.9%) | $5.84 M(+2.0%) |
| Sep 2016 | - | $5.72 M(+63.4%) |
| Jun 2016 | - | $3.50 M(-3.3%) |
| Mar 2016 | - | $3.62 M(+33.3%) |
| Dec 2015 | $2.72 M(+24.2%) | $2.72 M(-19.9%) |
| Sep 2015 | - | $3.39 M(+40.9%) |
| Jun 2015 | - | $2.41 M(-10.1%) |
| Mar 2015 | - | $2.68 M(+22.3%) |
| Dec 2014 | $2.19 M(+86.7%) | $2.19 M(-17.2%) |
| Sep 2014 | - | $2.64 M(-12.5%) |
| Jun 2014 | - | $3.02 M(+12.2%) |
| Mar 2014 | - | $2.69 M(+129.6%) |
| Dec 2013 | $1.17 M(+276.8%) | $1.17 M(+2.8%) |
| Sep 2013 | - | $1.14 M(+10.9%) |
| Jun 2013 | - | $1.03 M(+158.3%) |
| Mar 2013 | - | $398.00 K(+28.0%) |
| Dec 2012 | $311.00 K(-37.9%) | $311.00 K(-52.1%) |
| Sep 2012 | - | $649.00 K(-14.8%) |
| Jun 2012 | - | $762.00 K(+52.1%) |
| Dec 2011 | $501.00 K | $501.00 K |
FAQ
- What is Regulus Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Regulus Therapeutics?
- What is Regulus Therapeutics annual accounts payable year-on-year change?
- What is Regulus Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly accounts payable year-on-year change?
What is Regulus Therapeutics annual accounts payable?
The current annual accounts payable of RGLS is $204.00 K
What is the all time high annual accounts payable for Regulus Therapeutics?
Regulus Therapeutics all-time high annual accounts payable is $5.84 M
What is Regulus Therapeutics annual accounts payable year-on-year change?
Over the past year, RGLS annual accounts payable has changed by +$29.00 K (+16.57%)
What is Regulus Therapeutics quarterly accounts payable?
The current quarterly accounts payable of RGLS is $792.00 K
What is the all time high quarterly accounts payable for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly accounts payable is $5.84 M
What is Regulus Therapeutics quarterly accounts payable year-on-year change?
Over the past year, RGLS quarterly accounts payable has changed by $0.00 (0.00%)